The firm has described a 1% drop in revenues for the past financial year, citing the influence of the coronavirus disaster, Brexit and investment into the firm as good reasons for the muted growth.
Travers PEP Plummets 20% As Profits and Revenue Dip Too
More Post
Virtual Check-In with Your Reference Librarians Aug. 5
FDA issues digital health policy guidance for multiple function device products
Cash Flows for Commercial Leases During COVID-19